DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The "Global Addiction Disorder Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Addiction Disorder epidemiology, Addiction Disorder diagnosed patients, and Addiction Disorder treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Addiction Disorder derived from epidemiological analysis, patients diagnosed with Addiction Disorder, and patients treated with a drug therapy.

The research study helps executives estimate Addiction Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Addiction Disorder prevalence, Addiction Disorder diagnosis rate, and Addiction Disorder treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

Addiction Disorder Patient Flow Addiction Disorder Prevalence Addiction Disorder Diagnosed Patients Addiction Disorder Treated Patients

Key Topics Covered

1. Addiction Disorder: Disease Definition

2. Global Addiction Disorder Patient Flow

2A. Global Addiction Disorder Prevalence

2B. Global Addiction Disorder Diagnosed Patients

2C. Global Addiction Disorder Treated Patients

3. Addiction Disorder Patient Flow in the US

3A. Addiction Disorder Prevalence in the US

3B. Addiction Disorder Diagnosed Patients in the US

3C. Addiction Disorder Treated Patients in the US

4. Addiction Disorder Patient Flow in Europe

4A. Addiction Disorder Prevalence in Europe

4B. Addiction Disorder Diagnosed Patients in Europe

4C. Addiction Disorder Treated Patients in Europe

5. Addiction Disorder Patient Flow in Germany

5A. Addiction Disorder Prevalence in Germany

5B. Addiction Disorder Diagnosed Patients in Germany

5C. Addiction Disorder Treated Patients in Germany

6. Addiction Disorder Patient Flow in France

6A. Addiction Disorder Prevalence in France

6B. Addiction Disorder Diagnosed Patients in France

6C. Addiction Disorder Treated Patients in France

7. Addiction Disorder Patient Flow in Spain

7A. Addiction Disorder Prevalence in Spain

7B. Addiction Disorder Diagnosed Patients in Spain

7C. Addiction Disorder Treated Patients in Spain

8. Addiction Disorder Patient Flow in Italy

8A. Addiction Disorder Prevalence in Italy

8B. Addiction Disorder Diagnosed Patients in Italy

8C. Addiction Disorder Treated Patients in Italy

9. Addiction Disorder Patient Flow in UK

9A. Addiction Disorder Prevalence in UK

9B. Addiction Disorder Diagnosed Patients in UK

9C. Addiction Disorder Treated Patients in UK

10. Addiction Disorder Patient Flow in Japan

10A. Addiction Disorder Prevalence in Japan

10B. Addiction Disorder Diagnosed Patients in Japan

10C. Addiction Disorder Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/ncln93/global_addiction?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612006455/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Addiction Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 04:07 PM/DISC: 06/12/2018 04:07 PM

http://www.businesswire.com/news/home/20180612006455/en